Fortrea Optimizes Site Matching On Retina Clinical Trials

Fortrea partnered with Verana Health to address challenges in engaging clinical trial sites within the crowded retina research landscape. With 40–50 sites dominating the field, Fortrea needed a more efficient and personalized method to identify new, underutilized trial sites. By leveraging real-world data from Verana Health’s access to the American Academy of Ophthalmology IRIS® Registry, Fortrea gained aggregated patient insights that streamlined site feasibility assessments and reduced manual pre-screening burdens. This data-driven approach enabled “warm introductions” to potential sites based on existing patient data, improving engagement and outreach efficiency. As a result, Fortrea significantly expanded its site network, reduced the feasibility process by 2–3 weeks, and improved the precision of site-to-trial matching. The partnership lowered the site match ratio by nearly half, accelerating trial startup timelines and enhancing resource allocation.